These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 30743049)
1. Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy. Li H; Yan W; Suo X; Peng H; Yang X; Li Z; Zhang J; Liu D Biomaterials; 2019 Apr; 200():1-14. PubMed ID: 30743049 [TBL] [Abstract][Full Text] [Related]
2. Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy. Liu D; Hong Y; Li Y; Hu C; Yip TC; Yu WK; Zhu Y; Fong CC; Wang W; Au SK; Wang S; Yang M Theranostics; 2020; 10(3):1181-1196. PubMed ID: 31938059 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
4. Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells. Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X Biomaterials; 2016 Aug; 97():62-73. PubMed ID: 27162075 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365 [TBL] [Abstract][Full Text] [Related]
6. Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells. Tsai PH; Wang ML; Chang JH; Yarmishyn AA; Nhi Nguyen PN; Chen W; Chien Y; Huo TI; Mou CY; Chiou SH ACS Appl Mater Interfaces; 2019 Jun; 11(22):19808-19818. PubMed ID: 31066542 [TBL] [Abstract][Full Text] [Related]
7. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy. Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051 [TBL] [Abstract][Full Text] [Related]
8. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells. Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423 [TBL] [Abstract][Full Text] [Related]
9. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050 [TBL] [Abstract][Full Text] [Related]
10. Enhanced Sensitivity of Cancer Stem Cells to Chemotherapy Using Functionalized Mesoporous Silica Nanoparticles. Chen Z; Zhu P; Zhang Y; Liu Y; He Y; Zhang L; Gao Y Mol Pharm; 2016 Aug; 13(8):2749-59. PubMed ID: 27348602 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway. Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741 [TBL] [Abstract][Full Text] [Related]
12. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668 [TBL] [Abstract][Full Text] [Related]
13. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218 [TBL] [Abstract][Full Text] [Related]
14. A novel double-targeted nondrug delivery system for targeting cancer stem cells. Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy. Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells. Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852 [TBL] [Abstract][Full Text] [Related]
17. Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer. You YH; Lin YF; Nirosha B; Chang HT; Huang YF Nanotheranostics; 2019; 3(3):266-283. PubMed ID: 31263658 [TBL] [Abstract][Full Text] [Related]
18. Quantum dot nanoprobe-based high-content monitoring of notch pathway inhibition of breast cancer stem cell by capsaicin. Shim Y; Song JM Mol Cell Probes; 2015 Dec; 29(6):376-381. PubMed ID: 26384954 [TBL] [Abstract][Full Text] [Related]
19. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells. Sun R; Liu Y; Li SY; Shen S; Du XJ; Xu CF; Cao ZT; Bao Y; Zhu YH; Li YP; Yang XZ; Wang J Biomaterials; 2015 Jan; 37():405-14. PubMed ID: 25453968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]